Authors: | Benson, A. B. 3rd; Venook, A. P.; Al-Hawary, M. M.; Cederquist, L.; Chen, Y. J.; Ciombor, K. K.; Cohen, S.; Cooper, H. S.; Deming, D.; Engstrom, P. F.; Grem, J. L.; Grothey, A.; Hochster, H. S.; Hoffe, S.; Hunt, S.; Kamel, A.; Kirilcuk, N.; Krishnamurthi, S.; Messersmith, W. A.; Meyerhardt, J.; Mulcahy, M. F.; Murphy, J. D.; Nurkin, S.; Saltz, L.; Sharma, S.; Shibata, D.; Skibber, J. M.; Sofocleous, C. T.; Stoffel, E. M.; Stotsky-Himelfarb, E.; Willett, C. G.; Wuthrick, E.; Gregory, K. M.; Freedman-Cass, D. A. |
Article Title: | Anal carcinoma, version 2.2018: Clinical Practice Guidelines in Oncology |
Abstract: | The NCCN Guidelines for Anal Carcinoma provide recommendations for the management of patients with squamous cell carcinoma of the anal canal or perianal region. Primary treatment of anal cancer usually includes chemoradiation, although certain lesions can be treated with margin-negative local excision alone. Disease surveillance is recommended for all patients with anal carcinoma because additional curative-intent treatment is possible. A multidisciplinary approach including physicians from gastroenterology, medical oncology, surgical oncology, radiation oncology, and radiology is essential for optimal patient care. © JNCCN—Journal of the National Comprehensive Cancer Network. |
Journal Title: | Journal of the National Comprehensive Cancer Network |
Volume: | 16 |
Issue: | 7 |
ISSN: | 1540-1405 |
Publisher: | Harborside Press |
Date Published: | 2018-07-01 |
Start Page: | 852 |
End Page: | 871 |
Language: | English |
DOI: | 10.6004/jnccn.2018.0060 |
PROVIDER: | scopus |
PUBMED: | 30006428 |
DOI/URL: | |
Notes: | Review -- Export Date: 1 August 2018 -- Source: Scopus |